105 related articles for article (PubMed ID: 12801605)
1. Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice.
Garber DW; Handattu S; Aslan I; Datta G; Chaddha M; Anantharamaiah GM
Atherosclerosis; 2003 Jun; 168(2):229-37. PubMed ID: 12801605
[TBL] [Abstract][Full Text] [Related]
2. Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.
Nayyar G; Handattu SP; Monroe CE; Chaddha M; Datta G; Mishra VK; Keenum TD; Palgunachari MN; Garber DW; Anantharamaiah GM
Atherosclerosis; 2010 Dec; 213(2):449-57. PubMed ID: 21030022
[TBL] [Abstract][Full Text] [Related]
3. Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo.
Datta G; Garber DW; Chung BH; Chaddha M; Dashti N; Bradley WA; Gianturco SH; Anantharamaiah GM
J Lipid Res; 2001 Jun; 42(6):959-66. PubMed ID: 11369804
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM
Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190
[TBL] [Abstract][Full Text] [Related]
5. Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.
Handattu SP; Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Mishra VK; Datta G; Anantharamaiah GM
Atherosclerosis; 2013 Mar; 227(1):58-64. PubMed ID: 23159231
[TBL] [Abstract][Full Text] [Related]
6. The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts.
Datta G; Chaddha M; Garber DW; Chung BH; Tytler EM; Dashti N; Bradley WA; Gianturco SH; Anantharamaiah GM
Biochemistry; 2000 Jan; 39(1):213-20. PubMed ID: 10625496
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E mimetics and cholesterol-lowering properties.
Sharifov OF; Nayyar G; Garber DW; Handattu SP; Mishra VK; Goldberg D; Anantharamaiah GM; Gupta H
Am J Cardiovasc Drugs; 2011 Dec; 11(6):371-81. PubMed ID: 22149316
[TBL] [Abstract][Full Text] [Related]
8. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.
Shimano H; Yamada N; Katsuki M; Yamamoto K; Gotoda T; Harada K; Shimada M; Yazaki Y
J Clin Invest; 1992 Nov; 90(5):2084-91. PubMed ID: 1430232
[TBL] [Abstract][Full Text] [Related]
9. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes.
Goldberg IJ; Hu Y; Noh HL; Wei J; Huggins LA; Rackmill MG; Hamai H; Reid BN; Blaner WS; Huang LS
Diabetes; 2008 Jun; 57(6):1674-82. PubMed ID: 18346984
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
Anantharamaiah GM; Garber DW; White CR
Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
[TBL] [Abstract][Full Text] [Related]
11. Sustained-delivery of an apolipoprotein E-peptidomimetic using multivesicular liposomes lowers serum cholesterol levels.
Ramprasad MP; Anantharamaiah GM; Garber DW; Katre NV
J Control Release; 2002 Feb; 79(1-3):207-18. PubMed ID: 11853932
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.
Handattu SP; Datta G; Epand RM; Epand RF; Palgunachari MN; Mishra VK; Monroe CE; Keenum TD; Chaddha M; Anantharamaiah GM; Garber DW
J Lipid Res; 2010 Dec; 51(12):3491-9. PubMed ID: 20841495
[TBL] [Abstract][Full Text] [Related]
13. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
14. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
[TBL] [Abstract][Full Text] [Related]
15. Effects of feeding fish oil on the properties of lipoproteins isolated from rhesus monkeys consuming an atherogenic diet.
Soltys PA; Mazzone T; Wissler RW; Vahed S; Rangnekar V; Lukens J; Vesselinovitch D; Getz GS
Atherosclerosis; 1989 Apr; 76(2-3):103-15. PubMed ID: 2730707
[TBL] [Abstract][Full Text] [Related]
16. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
[TBL] [Abstract][Full Text] [Related]
17. Plasma carboxyl ester lipase activity modulates apolipoprotein B-containing lipoprotein metabolism in a transgenic mouse model.
Li L; Weng W; Harrison EH; Fisher EA
Metabolism; 2008 Oct; 57(10):1361-8. PubMed ID: 18803939
[TBL] [Abstract][Full Text] [Related]
18. Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques.
Anantharamaiah GM; Garber DW; Goldberg D; Morrel E; Datta G; Palgunachari MN; Register TC; Appt SE; White CR
J Lipid Res; 2018 Nov; 59(11):2075-2083. PubMed ID: 30201630
[TBL] [Abstract][Full Text] [Related]
19. An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo.
Nikoulin IR; Curtiss LK
J Clin Invest; 1998 Jan; 101(1):223-34. PubMed ID: 9421485
[TBL] [Abstract][Full Text] [Related]
20. Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H.
Ishida BY; Blanche PJ; Nichols AV; Yashar M; Paigen B
J Lipid Res; 1991 Apr; 32(4):559-68. PubMed ID: 1856605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
